ATLANTA — People with rare cancers have been out of luck — not only do most lack good treatments but drug companies also don't pursue them because of small potential sales. Now, a federal study that pools these folks gives them strength in numbers and new options.
Federal study gives new options for people with rare cancers
Results suggest that for people with unusual diseases, there seems to be a way to predict who will – and will not – benefit from a drug combo that boosts the immune system
